Literature DB >> 10628772

Transduction of dendritic cell progenitors with a retroviral vector encoding viral interleukin-10 and enhanced green fluorescent protein allows purification of potentially tolerogenic antigen-presenting cells.

T Takayama1, H Tahara, A W Thomson.   

Abstract

BACKGROUND: Dendritic cells (DC) are important antigen-presenting cells that play critical roles in the initiation and modulation of immune responses. Genetic engineering of DC to express immunosuppressive molecules is a novel approach to the inhibition of allograft rejection. Retroviral delivery of viral interleukin (vIL)-10 to replicating myeloid DC progenitors (DCp) impairs their T-cell stimulatory capacity and promotes the induction of antigen-specific T-cell hyporesponsiveness. However, transduction efficiency with retroviral vectors is comparatively low. Enhanced green fluorescent protein (EGFP) is important both as a marker of gene transduction and for the selection of transduced cells. Our aims were to construct a retroviral vector encoding both vIL-10 and EGFP, to positively select transduced DC, and to assess the impact of these highly purified, vIL-10-secreting antigen-presenting cells on allogeneic T-cell responses.
METHODS: DCp propagated from bone marrow of C57BL10 (H2b) mice in granulocyte-macrophage colony-stimulating factor (GM-CSF)+IL-4 were transduced with a retroviral vector encoding both vIL-10 and EGFP by centrifugal enhancement. Gene transfer efficiency was determined by flow cytometry. Transduced cells were flow sorted, and vIL-10 secretion was quantified by ELISA. DC function was assessed by the ability of the cells to induce naive allogeneic (C3H; H2k) T-cell proliferation and cytotoxic T lymphocyte generation.
RESULTS: Retrovirally transduced DC expressed both vIL-10 and EGFP gene products. Approximately 20% of unsorted cells expressed EGFP, as determined by flow cytometry. vIL-10 was produced at a mean rate of 31 ng/40 hr/10(6) cells. After sorting, the incidence of EGFP+ DC was increased dramatically to at least 95%, and the production of vIL-10 was increased approximately three- to fourfold, to a mean of 107 ng/40 hr/10(6) cells. These highly purified, vIL-10-secreting DC exhibited markedly diminished capacity to induce allogeneic T-cell proliferative and cytotoxic responses.
CONCLUSIONS: DCp retrovirally transduced to express both vIL-10 and EGFP can be rapidly identified and sorted to high levels of purity. The availability of highly enriched preparations of vIL-10-transduced DC facilitates studies of their immunoregulatory function and may enhance their therapeutic potential in transplantation or autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10628772     DOI: 10.1097/00007890-199912270-00015

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  8 in total

Review 1.  Dendritic cells, T cell tolerance and therapy of adverse immune reactions.

Authors:  P A Morel; M Feili-Hariri; P T Coates; A W Thomson
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

2.  Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantation.

Authors:  Christoph H Schimmelpfennig; Stephan Schulz; Caroline Arber; Jeanette Baker; Ingo Tarner; Jacqueline McBride; Christopher H Contag; Robert S Negrin
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

3.  Effects of herpes simplex virus amplicon transduction on murine dendritic cells.

Authors:  Yahui Grace Chiu; William J Bowers; Seung T Lim; Deborah A Ryan; Howard J Federoff
Journal:  Hum Gene Ther       Date:  2009-05       Impact factor: 5.695

Review 4.  Cytokine-adjuvanted HIV-DNA vaccination strategies.

Authors:  Franco Lori; David B Weiner; Sandra A Calarota; Laurene M Kelly; Julianna Lisziewicz
Journal:  Springer Semin Immunopathol       Date:  2006-10-20

Review 5.  Current status and prospects for gene and cell therapeutics for type 1 diabetes mellitus.

Authors:  Nick Giannoukakis; Massimo Trucco
Journal:  Rev Endocr Metab Disord       Date:  2003-12       Impact factor: 9.306

6.  ER intrabody-mediated inhibition of interferon α secretion by mouse macrophages and dendritic cells.

Authors:  Konrad Büssow; Philipp Themann; Sabine Luu; Paul Pentrowski; Claudia Harting; Mira Majewski; Veith Vollmer; Mario Köster; Martina Grashoff; Rainer Zawatzky; Joop Van den Heuvel; Andrea Kröger; Thomas Böldicke
Journal:  PLoS One       Date:  2019-04-16       Impact factor: 3.240

7.  LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells.

Authors:  Amy E Anderson; David J Swan; Bethan L Sayers; Rachel A Harry; Angela M Patterson; Alexei von Delwig; John H Robinson; John D Isaacs; Catharien M U Hilkens
Journal:  J Leukoc Biol       Date:  2008-11-06       Impact factor: 4.962

8.  Alarming dendritic cells for Th2 induction.

Authors:  Andrew S MacDonald; Rick M Maizels
Journal:  J Exp Med       Date:  2008-01-14       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.